NEW YORK (PRWEB)
December 28, 2022
The Healthcare Technology Report is pleased to announce The Top 25 Healthcare Technology Leaders of Vancouver for 2022. The software consulting firm Moove It recently ranked Vancouver third among Canadian cities on its Healthtech Index, which assesses cities around the world against 18 factors that indicate the maturity and advancement of their healthtech sectors. For Vancouver, both funding and employment scored particularly high, and it’s no wonder why, given the awardees on this year’s list and the revolutionary companies they represent. Across a range of specialties, from pharmaceuticals to nanotechnology, genomics, and data analytics, among many others, these companies and their leaders are producing innovations that are having significant impacts on patients, their families, and physicians in Vancouver and beyond.
A few of the distinguished leaders on this list include James Taylor, Co-Founder, and CEO of Precision NanoSystems, who has grown his company to become the leading technology provider for the development of nanomedicines. Meanwhile, Founder and CEO Dr. Michael Gilbert has grown Semios into a leader in the agtech sector, helping farmers use data to optimize every acre and predict, identify, and prevent pest and disease pressure. And Dr. Thomas D. Madden, President, and CEO of Acuitas Therapeutics, is a world-renowned expert in the area of nanotechnology and has guided his company to its position as a global leader through the development and application of lipid nanoparticle (LNP) technology.
Choosing just 25 awardees for this list is never easy, but these leaders stood out through their dedication to advancing healthtech innovation in Vancouver and in the wider market — and they did so from a variety of positions, from CEO to CFO, COO, Senior Vice President, and Senior Director. Please join us in celebrating The Top 25 Healthcare Technology Leaders of Vancouver for 2022.
Ian Mortimer (Xenon Pharmaceuticals), James Taylor (Precision NanoSystems), Kevin Chaplin (Kardium), Dr. Michael Gilbert (Semios), Gordon McCauley (adMare BioInnovations), David Main (Notch Therapeutics), Dr. Bill Hunter (Canary Medical), Suzanne Gill (Genome British Columbia), Peter Li (Applied Biological Materials), Benjamin Arazy (Arazy Group Consultants), Dr. Thomas D. Madden (Acuitas Therapeutics), Karim Qayumi (Interactive Health International), Dr. Kishor Wasan (Neglected Global Diseases Initiative, UBC), Sean Marshman (STEMCELL Technologies), Glen Ibbott (Aurora Cannabis), Tim Fernback (Konscious Foods), Neil Klompas (Zymeworks), Andrew Booth (AbCellera), Lawrence Wong (bioLytical), Sukhi Jagpal (Sierra Oncology), Tanya Colhoun (PPD, part of Thermo Fisher Scientific), Tiffany Chiu (AbCellera), Michael Gallad (Illumina), Imelda Centeno (Unilab), Paul Tardi (Jazz Pharmaceuticals).
The full article can be read at https://thehealthcaretechnologyreport.com/
About The Healthcare Technology Report
The Healthcare Technology Report provides market research and insights, business news, investment activity updates, and important corporate developments related to the healthcare technology sector. Based in New York City, the firm is run by a seasoned team of editors, writers, and media professionals highly knowledgeable on healthcare technology and the various companies, executives, and investors that make up the sector.
Share article on social media or email: